As of 2025-07-16, the EV/EBITDA ratio of Taro Pharmaceutical Industries Ltd (TARO) is
20.67.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TARO's latest enterprise value
is 1,192.96 mil USD. TARO's TTM EBITDA according to its financial statements is
57.71 mil USD. Dividing these 2
quantities gives us the above TARO EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
8.7x - 15.2x |
11.2x |
| Forward P/E multiples |
10.7x - 17.9x |
14.6x |
| Fair Price |
24.62 - 56.75 |
38.39 |
| Upside |
-42.7% - 32.1% |
-10.7% |